Dr. Leslie J. Padrnos, MD

Dr. Padrnos practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Padrnos' NPI, 1225328545, was assigned on April 8, 2011. Dr. Padrnos graduated from University of Arizona College of Medicine - Phoenix in 2011. Dr. Padrnos holds Arizona license 45979.

Dr. Padrnos' primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Padrnos' primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Padrnos is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Padrnos to 1 more hospital and 2 medical groups, each named with a free account. Dr. Padrnos' employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padrnos practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Padrnos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Padrnos' licenses on file in 2 states: Arizona and Washington.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Padrnos treats.

CMS data shows 55,805 Medicare services from Dr. Padrnos across 52 procedure codes in 2024, for 656 Medicare patients. Medicare paid $1,373,419 for them.

CMS counts 656 Medicare patients who saw Dr. Padrnos in 2024. The largest group is 65 to 74, with 320 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padrnos' median patient age at 69, with 51% women.

In 2024, Dr. Padrnos wrote 50 Medicare Part D claims for 29 patients. 30% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $20,420 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Padrnos for performance year 2024, reported as part of a group. Dr. Padrnos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Padrnos as offering telehealth.

Dmand AI links 31 papers to Dr. Padrnos, published from 2014 to 2024. 2016 was the busiest year, with 4. The most frequent topics are COVID-19, Thrombosis and Venous Thromboembolism. Dr. Padrnos has published most often in Mayo Clin Proc. Dr. Padrnos' most frequent co-authors are Damon Eugene Houghton, MD, Ruben Anthony Mesa, MD and Waldemar Edward Wysokinski, MD.

Dmand AI links Dr. Padrnos to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Intracranial Embolism and Thrombosis, Thrombocytopenia and Intracranial Thrombosis.

CMS Open Payments shows 9 general payments to Dr. Padrnos from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Alexion Pharmaceuticals, Inc. paid the most, $228. It also lists 3 research payments totaling $29,450 from 2021 to 2022.

Dr. Padrnos graduated from University of Arizona College of Medicine - Phoenix in 2011.

Dr. Padrnos is in network with 10 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.